David Ridley

David Ridley

Duke University

H-index: 17

North America-United States

About David Ridley

David Ridley, With an exceptional h-index of 17 and a recent h-index of 10 (since 2020), a distinguished researcher at Duke University, specializes in the field of innovation, pricing, pharmaceuticals, biotech.

His recent articles reflect a diverse array of research interests and contributions to the field:

European priority review vouchers for neglected disease product development

FDA Global Drug Inspections: Surveillance Of Manufacturing Establishments Remains Well Below Pre-COVID-19 Levels: Study examines FDA surveillance inspections of manufacturing …

Consequences of a shortage and rationing: Evidence from a pediatric vaccine

How To Make The Most Of A New Voucher Program, Encourage Pesticide Development, And Prevent Disease

How to motivate drug development for infectious diseases

Design of a Transferable Exclusivity Voucher Program

​ US Tropical Disease Priority Review Vouchers: Lessons In Promoting Drug Development And Access: Article examines infectious disease drug and vaccine development.

Does Medicare reimbursement drive up drug launch prices?

David Ridley Information

University

Position

___

Citations(all)

1151

Citations(since 2020)

366

Cited By

915

hIndex(all)

17

hIndex(since 2020)

10

i10Index(all)

24

i10Index(since 2020)

11

Email

University Profile Page

Duke University

Google Scholar

View Google Scholar Profile

David Ridley Skills & Research Interests

innovation

pricing

pharmaceuticals

biotech

Top articles of David Ridley

Title

Journal

Author(s)

Publication Date

European priority review vouchers for neglected disease product development

BMJ Global Health

David B Ridley

Agustín Martín Lasanta

Ffion Storer Jones

Sarah K Ridley

2024/1/1

FDA Global Drug Inspections: Surveillance Of Manufacturing Establishments Remains Well Below Pre-COVID-19 Levels: Study examines FDA surveillance inspections of manufacturing …

Health Affairs

Emily Cuddy

Yun Peng Lu

David B Ridley

2023/12/1

Consequences of a shortage and rationing: Evidence from a pediatric vaccine

Journal of Health Economics

Eli Liebman

Emily C Lawler

Abe Dunn

David B Ridley

2023/12/1

How To Make The Most Of A New Voucher Program, Encourage Pesticide Development, And Prevent Disease

Health Affairs Forefront

Jeffrey Moe

Alan Ayers

Nick Hamon

Derric Nimmo

David B Ridley

2023

How to motivate drug development for infectious diseases

Health Affairs Forefront

Beth Boyer

Adam Kroetsch

Andrea Thoumi

David B Ridley

2022

Design of a Transferable Exclusivity Voucher Program

Duke Margolis Center for Health Policy white paper

Beth Boyer

Adam Kroetsch

David Ridley

2022

​ US Tropical Disease Priority Review Vouchers: Lessons In Promoting Drug Development And Access: Article examines infectious disease drug and vaccine development.

Health Affairs

David B Ridley

Pranav Ganapathy

Hannah E Kettler

2021/8/1

Does Medicare reimbursement drive up drug launch prices?

Review of Economics and Statistics

David B Ridley

Chung-Ying Lee

2020/12/1

See List of Professors in David Ridley University(Duke University)

Co-Authors

H-index: 97
Frank A. Sloan

Frank A. Sloan

Duke University

H-index: 54
Shelby Reed

Shelby Reed

Duke University

H-index: 38
Peter Arcidiacono

Peter Arcidiacono

Duke University

H-index: 36
Paul A. Zandbergen

Paul A. Zandbergen

Vancouver Island University

H-index: 24
Margaret Kyle

Margaret Kyle

MINES ParisTech

H-index: 23
Paul B. Ellickson

Paul B. Ellickson

University of Rochester

academic-engine